Cyclacel Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Cyclacel Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 1.81M shares, a 85.7% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.81M -10.8M -85.7% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 1.32M -11.2M -89.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.06M +431K +68.6% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 12.6M +104K +0.83% Sep 30, 2023 10-Q 2023-11-29
Q2 2023 12.6M +1.29M +11.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 12.5M +2.55M +25.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 628K -9.36M -93.7% Dec 31, 2022 10-K 2024-03-21
Q3 2022 12.5M +2.74M +28% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 11.4M +2.12M +22.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 9.99M +759K +8.22% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 9.99M +3.75M +60% Dec 31, 2021 10-K/A 2023-11-29
Q3 2021 9.8M +4.93M +101% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 9.23M +4.37M +89.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 9.23M +8.37M +974% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 6.25M +5.39M +626% Dec 31, 2020 10-K 2022-03-30
Q3 2020 4.86M -12.3M -71.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 4.86M -12.3M -71.7% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 860K -16.3M -95% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 860K -11.6M -93.1% Dec 31, 2019 10-K 2021-03-01
Q3 2019 17.2M +5.2M +43.4% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 17.2M +5.2M +43.4% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 17.2M +5.2M +43.4% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 12.5M +500K +4.17% Dec 31, 2018 10-K 2020-03-05
Q3 2018 12M +300K +2.57% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 12M +7.56M +170% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 12M +7.72M +181% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 12M +7.74M +182% Dec 31, 2017 10-K 2019-03-28
Q3 2017 11.7M +7.45M +175% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 4.44M +1.43M +47.6% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 4.27M -31.3M -88% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 4.26M +1.29M +43.6% Dec 31, 2016 10-K 2018-03-30
Q3 2016 4.25M -30.5M -87.8% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 3.01M -31.4M -91.3% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 35.6M +1.19M +3.47% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 2.97M -20.2M -87.2% Dec 31, 2015 10-K 2017-03-31
Q3 2015 34.7M +12M +53% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 34.4M +11.7M +51.6% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 34.4M +14.6M +73.5% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 23.2M +3.83M +19.8% Dec 31, 2014 10-K 2016-03-29
Q3 2014 22.7M +3.98M +21.3% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 22.7M +4.96M +28% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 19.8M +8.94M +82.1% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 19.4M +10.7M +123% Dec 31, 2013 10-K 2015-03-31
Q3 2013 18.7M +10.3M +122% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 17.7M -41.3M -70% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 10.9M -48.1M -81.6% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 8.69M +941K +12.1% Dec 31, 2012 10-K 2014-03-26
Q3 2012 8.43M -45.8M -84.4% Sep 30, 2012 10-Q 2012-11-16
Q2 2012 59M +12.4M +26.6% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 59M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 7.75M -38.8M -83.4% Dec 31, 2011 10-K 2013-04-01
Q3 2011 54.2M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 46.6M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 46.6M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.